Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a history of exacerbations. Daliresp is also referred to by its drug name, Roflumilast.
Daliresp is a phosphodiesterase inhibitor. Daliresp is believed to work by decreasing the amount of certain molecules that cause inflammation.
How do I take it?
Prescribing information states that Daliresp is generally taken once daily.
Daliresp comes in tablet form.
The FDA-approved label for Daliresp lists common side effects including dizziness, decreased appetite, diarrhea, weight loss, nausea, back pain, flu-like symptoms, and trouble sleeping.
Rare but serious side effects listed for Dailyresp include suicidal thinking and weight loss.